Surprisingly, numerous clinical studies indicate that a significant increase in cancer incidence is a serious complication of transplant recipients receiving long-term immunosupressive therapy.29 The mechanism behind this increased rate of cancer is not yet understood; however, such studies indicate another oncogenic pathway other than inhibition of calcineurin in which RCAN1 may be involved. This evidence concerns the gene RCAN1 and cancer.